comparemela.com

Latest Breaking News On - Pre funded warrant - Page 1 : comparemela.com

ENLIVEX THERAPEUTICS : CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2024 AND DECEMBER 31, 2023 AND FOR THE THREE MONTH PERIODS ENDED MARCH 31, 2024 AND 2023 ENLIVEX THERAPEUTICS LTD. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2024 AND DECEMBER 31, 2023 AND FOR THE THREE MONTH PERIODS ENDED MARCH 31, 2024 AND 2023 INDEX TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS Form 6 K

ENLIVEX THERAPEUTICS LTD. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS AS OF MARCH 31, 2024 AND DECEMBER 31, 2023 AND FOR THE THREE-MONTH PERIODS.

Tel-aviv
Israel
Israeli
State-of-israel
Dror-mevorach
Hadassah-university-hospital
Israeli-innovation-authority
Cantor-fitzgerald-co
Company-annual-report-on-form
Drug-administration
Hc-wainwright-co
Tel-aviv-stock-exchange

Bionomics : SECURITIES PURCHASE AGREEMENT - Form 6-K

SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT is made and entered into as of May 31, 2024 by and among Bionomics Limited, a public company incorporated under.

Australia
Sacramento
California
United-states
New-york
New-york-stock-exchange
Manhattan
American
Commonwealth-of-australia
Australian
Spyros-papapetropoulos
Theodorej-ghorra

Enlivex Therapeutics : Immediate Report - MarketScreener

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of.

New-york-stock-exchange
New-york
United-states
State-of-new-york
Miami
Florida
Washington
Israel
Tel-aviv
Israeli
State-of-israel
American

Applied DNA Sciences, Inc.: Applied DNA Announces Pricing of $12 Million Public Offering

STONY BROOK, NY / ACCESSWIRE / May 28, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced the pricing of a public

New-york
United-states
Stony-brook
Syndicate-department
Laidlaw-company-united-kingdom-ltd
Sciences-inc
Securities-exchange
Linkedin
Spindle-biotech-inc
Exchange-commission
Nasdaq

Applied DNA Sciences Stock Tanks Over 65%

Shares of Applied DNA Sciences, Inc. (APDN) tanked over 65% on Tuesday morning after the company announced the pricing of $12 million public offering. APDN is currently trading at $0.

Mdx-testing-services
Production-services
Nasdaq
Sciences-inc
Seriesb-warrant
Common-share
Pre-funded-warrant
Testing-services

vimarsana © 2020. All Rights Reserved.